melatonin has been researched along with Bronchopulmonary Dysplasia in 5 studies
Bronchopulmonary Dysplasia: A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Human alveolar epithelial type II A549 cells were treated with hyperoxia as an in vitro model to investigate the antiapoptotic mechanism of melatonin." | 8.31 | Melatonin Protects Against Hyperoxia-Induced Apoptosis in Alveolar Epithelial type II Cells by Activating the MT2/PI3K/AKT/ETS1 Signaling Pathway. ( Chen, LP; He, F; Li, HY; Li, L; Liu, CZ; Wang, QF; Wei, WC; Yu, C, 2023) |
| "Melatonin is an effective antioxidant and free radical scavenger." | 7.11 | Evaluation of melatonin efficacy in prevention of bronchopulmonary dysplasia in preterm newborn infants. ( Fekri, M; Gharehbaghi, MM; Shaseb, E; Yeganedoust, S, 2022) |
| "Intrauterine inflammation is shown to be associated with preterm birth, fetal inflammatory response syndrome, and other pregnancy-related comorbidities such as central nervous system diseases including cerebral palsy and periventricular leukomalacia, pulmonary diseases such as bronchopulmonary dysplasia and respiratory distress syndrome, and necrotizing enterocolitis, to name a few." | 6.72 | Melatonin for the prevention of fetal injury associated with intrauterine inflammation. ( Kim, JM; Lee, JY; Lee, SY, 2021) |
| "Melatonin treatment reduced the proinflammatory cytokines and improved the clinical outcome." | 5.33 | Correlation among cytokines, bronchopulmonary dysplasia and modality of ventilation in preterm newborns: improvement with melatonin treatment. ( Barberi, I; Buggé, C; Buonocore, G; Gitto, E; Gitto, P; Reiter, RJ; Romeo, C; Sabatino, G; Trimarchi, G, 2005) |
| "Urinary melatonin concentration below the certain cut-off values in the early neonatal period may serve as one of the predictors of adverse outcomes such as BPD, ROP, and late-onset sepsis in the late neonatal period in preterm infants." | 4.31 | The relationship of melatonin concentration in preterm infants and adverse outcomes in the late neonatal period. ( Kozak, K; Pavlyshyn, Н; Sarapuk, I, 2023) |
| "Human alveolar epithelial type II A549 cells were treated with hyperoxia as an in vitro model to investigate the antiapoptotic mechanism of melatonin." | 4.31 | Melatonin Protects Against Hyperoxia-Induced Apoptosis in Alveolar Epithelial type II Cells by Activating the MT2/PI3K/AKT/ETS1 Signaling Pathway. ( Chen, LP; He, F; Li, HY; Li, L; Liu, CZ; Wang, QF; Wei, WC; Yu, C, 2023) |
| "Melatonin is an effective antioxidant and free radical scavenger." | 3.11 | Evaluation of melatonin efficacy in prevention of bronchopulmonary dysplasia in preterm newborn infants. ( Fekri, M; Gharehbaghi, MM; Shaseb, E; Yeganedoust, S, 2022) |
| "Intrauterine inflammation is shown to be associated with preterm birth, fetal inflammatory response syndrome, and other pregnancy-related comorbidities such as central nervous system diseases including cerebral palsy and periventricular leukomalacia, pulmonary diseases such as bronchopulmonary dysplasia and respiratory distress syndrome, and necrotizing enterocolitis, to name a few." | 2.72 | Melatonin for the prevention of fetal injury associated with intrauterine inflammation. ( Kim, JM; Lee, JY; Lee, SY, 2021) |
| "Melatonin treatment reduced the proinflammatory cytokines and improved the clinical outcome." | 1.33 | Correlation among cytokines, bronchopulmonary dysplasia and modality of ventilation in preterm newborns: improvement with melatonin treatment. ( Barberi, I; Buggé, C; Buonocore, G; Gitto, E; Gitto, P; Reiter, RJ; Romeo, C; Sabatino, G; Trimarchi, G, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (80.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gharehbaghi, MM | 1 |
| Yeganedoust, S | 1 |
| Shaseb, E | 1 |
| Fekri, M | 1 |
| Pavlyshyn, Н | 1 |
| Sarapuk, I | 1 |
| Kozak, K | 1 |
| He, F | 1 |
| Wang, QF | 1 |
| Li, L | 1 |
| Yu, C | 1 |
| Liu, CZ | 1 |
| Wei, WC | 1 |
| Chen, LP | 1 |
| Li, HY | 1 |
| Kim, JM | 1 |
| Lee, SY | 1 |
| Lee, JY | 1 |
| Gitto, E | 1 |
| Reiter, RJ | 1 |
| Sabatino, G | 1 |
| Buonocore, G | 1 |
| Romeo, C | 1 |
| Gitto, P | 1 |
| Buggé, C | 1 |
| Trimarchi, G | 1 |
| Barberi, I | 1 |
1 review available for melatonin and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Melatonin for the prevention of fetal injury associated with intrauterine inflammation.
Topics: Animals; Anti-Inflammatory Agents; Brain Injuries; Bronchopulmonary Dysplasia; Female; Fetal Disease | 2021 |
1 trial available for melatonin and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Evaluation of melatonin efficacy in prevention of bronchopulmonary dysplasia in preterm newborn infants.
Topics: Bronchopulmonary Dysplasia; Female; Humans; Infant; Infant, Newborn; Infant, Premature; Male; Melato | 2022 |
3 other studies available for melatonin and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
The relationship of melatonin concentration in preterm infants and adverse outcomes in the late neonatal period.
Topics: Bronchopulmonary Dysplasia; Humans; Infant; Infant, Newborn; Infant, Premature; Melatonin; Retinopat | 2023 |
Melatonin Protects Against Hyperoxia-Induced Apoptosis in Alveolar Epithelial type II Cells by Activating the MT2/PI3K/AKT/ETS1 Signaling Pathway.
Topics: Alveolar Epithelial Cells; Apoptosis; Bronchopulmonary Dysplasia; Epithelial Cells; Humans; Hyperoxi | 2023 |
Correlation among cytokines, bronchopulmonary dysplasia and modality of ventilation in preterm newborns: improvement with melatonin treatment.
Topics: Bronchopulmonary Dysplasia; Cytokines; Humans; Infant, Newborn; Interleukin-8; Melatonin; Oxygen; Po | 2005 |